November 2, 2011-Founder and Chief Scientific Officer Brooke Ligon announced today Mitokine has filed two patent applications for US and Foreign rights for additional intellectual property protection of the diabetes treatments discovered at Mitokine.
November 2, 2011 | Hancock, ME – Mitokine Bioscience Founder and Chief Scientific Officer Brooke Ligon announced that a search is underway for a new CEO now that Paul J. Myer, Interim CEO, has resumed his academic responsibilities as Executive in Res